Search
CalciMedica Inc
CALCAdd to Watchlist
1.000USD
+0.160+19.05%
Close 07-31 16:00（ET）Quotes delayed by 15 min
30.74MMarket Cap
LossP/E TTM
More Details of CalciMedica Inc Company
CalciMedica, Inc. is a clinical-stage biopharmaceutical company. The Company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for inflammatory and immunologic diseases. The Company's technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury. Its lead product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The Company is conducting a Phase IIb trial (called CARPO) for acute pancreatitis (AP) with systemic inflammatory response syndrome (SIRS), as well as supporting the ongoing Phase I/II asparaginase-induced pancreatic toxicity (AIPT) study (called CRSPA).
CalciMedica Inc Info
Ticker SymbolCALC
Company nameCalciMedica Inc
IPO dateSep 25, 2020
CEOLeheny (A. Rachel)
Number of employees14
Security typeOrdinary Share
Fiscal year-endSep 25
Address505 Coast Boulevard South
CityLA JOLLA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92037
Phone18589525500
Websitehttps://calcimedica.com/
Ticker SymbolCALC
IPO dateSep 25, 2020
CEOLeheny (A. Rachel)
Company Executives of CalciMedica Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Robert N. Wilson
Mr. Robert N. Wilson
Independent Chairman of the Board
Independent Chairman of the Board
1.60M
+73.70%
Mr. Eric W. Roberts
Mr. Eric W. Roberts
Chief Business Officer, Director
Chief Business Officer, Director
511.14K
+8.22%
Dr. Sudarshan Hebbar, M.D.
Dr. Sudarshan Hebbar, M.D.
Chief Medical Officer
Chief Medical Officer
170.49K
+73.02%
Dr. Frederic (Fred) Guerard, Pharm.D.
Dr. Frederic (Fred) Guerard, Pharm.D.
Director
Director
90.73K
--
Mr. Stephen Bardin
Mr. Stephen Bardin
Chief Financial Officer
Chief Financial Officer
41.00K
+2.44%
Dr. A. Rachel Leheny, Ph.D.
Dr. A. Rachel Leheny, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Fred Middleton
Mr. Fred Middleton
Independent Director
Independent Director
--
--
Mr. Allan L. Shaw
Mr. Allan L. Shaw
Independent Director
Independent Director
--
--
Mr. Michael J. Dunn
Mr. Michael J. Dunn
President, Chief Operating Officer
President, Chief Operating Officer
--
--
Dr. Kenneth A. Stauderman, Ph.D.
Dr. Kenneth A. Stauderman, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Robert N. Wilson
Mr. Robert N. Wilson
Independent Chairman of the Board
Independent Chairman of the Board
1.60M
+73.70%
Mr. Eric W. Roberts
Mr. Eric W. Roberts
Chief Business Officer, Director
Chief Business Officer, Director
511.14K
+8.22%
Dr. Sudarshan Hebbar, M.D.
Dr. Sudarshan Hebbar, M.D.
Chief Medical Officer
Chief Medical Officer
170.49K
+73.02%
Dr. Frederic (Fred) Guerard, Pharm.D.
Dr. Frederic (Fred) Guerard, Pharm.D.
Director
Director
90.73K
--
Mr. Stephen Bardin
Mr. Stephen Bardin
Chief Financial Officer
Chief Financial Officer
41.00K
+2.44%
Dr. A. Rachel Leheny, Ph.D.
Dr. A. Rachel Leheny, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
FAQs
Who are the top five shareholders of CalciMedica Inc?
The top five shareholders of CalciMedica Inc are: Mr. Robert N. Wilson
How many institutions hold shares of CalciMedica Inc (CALC)?
As of 2026Q1, 64 institutions hold shares of CalciMedica Inc, with a combined market value of approximately 6.41M, accounting for 40.73% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -2857443.00.